BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 214 filers reported holding BEAM THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $50,000 | -93.3% | 2,077 | -91.1% | 0.00% | – |
| Q2 2023 | $746,000 | +11.2% | 23,337 | +6.4% | 0.00% | – |
| Q1 2023 | $671,000 | -31.9% | 21,929 | -12.9% | 0.00% | – |
| Q4 2022 | $985,000 | -15.7% | 25,191 | +2.5% | 0.00% | – |
| Q3 2022 | $1,169,000 | -4.1% | 24,576 | -21.9% | 0.00% | – |
| Q2 2022 | $1,219,000 | +7.6% | 31,477 | +59.1% | 0.00% | – |
| Q1 2022 | $1,133,000 | +131.7% | 19,786 | +222.5% | 0.00% | – |
| Q4 2021 | $489,000 | +201.9% | 6,136 | +229.9% | 0.00% | – |
| Q3 2021 | $162,000 | -73.2% | 1,860 | -60.5% | 0.00% | – |
| Q2 2021 | $605,000 | +99.0% | 4,708 | +23.9% | 0.00% | – |
| Q1 2021 | $304,000 | +147.2% | 3,799 | +152.1% | 0.00% | – |
| Q4 2020 | $123,000 | +12200.0% | 1,507 | +5928.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 25 | +19.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 21 | -60.4% | 0.00% | – |
| Q1 2020 | $1,000 | – | 53 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $189,105,000 | 91.90% |
| PATHWAY CAPITAL MANAGEMENT, LP | 37,399 | $2,993,000 | 16.59% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,390 | $17,960,000 | 10.54% |
| HSG Holding Ltd | 796,089 | $63,719,000 | 4.73% |
| DC Investments Management, LLC | 21,010 | $1,682,000 | 4.17% |
| Monashee Investment Management LLC | 268,820 | $21,516,000 | 3.31% |
| Redmile Group, LLC | 2,532,523 | $202,703,000 | 2.86% |
| HAMILTON LANE ADVISORS LLC | 98,761 | $7,905,000 | 2.58% |
| Alphabet Inc. | 640,792 | $51,289,000 | 2.07% |
| Casdin Capital, LLC | 818,820 | $65,538,000 | 1.95% |